Wednesday

November 7, 2012

Thursday Friday Poster session

 

08.00 - 08.45

 

Poster Mounting

08.45 - 09.15

 

Opening Ceremony

 

 

 

Session 1

 

 Myelodysplastic Syndromes

09.15 - 09.35

IS 01

Cermak J
Adult and Pediatric MDS: What can we learn from each
other?

09.35 - 10.00

IS 02

M. van Heuvel-Eibrink
Biological aspects of pediatric MDS

10.00 - 10.15

CO 01

H.H.Helsmoortel
Study of the miRNome in childhood MDS (64)

10.15 - 10.30

CO 02

A. Manabe
Long-term FUP of more than 545 children with MDS and MPS (44)

 10.30 - 10.45

 

CO 03

A. Yoshimi
Secondary myeloid malignancy after IST in patients with SAA (95)

10.45 - 11.00

CO 04

K.Waack
Improved survival of children with secondary AML (2)

 

 

 

11.00 – 11.30

 

Coffee break

 

 

 

Session 2

 

Juvenile Myelomonocytic Leukemia I

11.30 - 11.55

IS 03

C.Kratz
Rasopathies

11.55 - 12.15

CO 05

C. M. Niemeyer
Clinical and molecular heterogeneity of JMML (108)

12.15 - 12.30

CO 06

H.Muramatsu
Comprehensive genetic analysis by deep sequencing in
JMML (59)

12.30 - 12.45

CO 07

M. Strullu
Does loss of heterozygosity of mutated CBL gene sign
JMML? (75)

12.45 - 13.00

CO 08

CB Goodwin
The PI3K catalytic subunit p110 delta is a crucial mediator
of leukemia-associated mutant PTPN11-induced GM-CSF hypersensitivity (34)

 

 

 

13.00 - 13.15

 

 Selected posters presentation

 

PO-01

de Vries: Molecular aberration in children with MDS

 

PO-06

Göhring: Clonal evolution of complec karyotypes in MDS with 5q-

 

PO-11

Bresolin: Case of monozygotic twins with concordant JMML

 

PO-12

Muramatsu: Somatic mosaicism for oncogenic RAS mutations in JMML

 

PO-19

Yabe: Allogeneic HSCT for 30 children with JMML

 

 

 

13.15-13.45

 

Lunch

 

 

 

13.45 - 14.30

 

Poster Session I

 

 

 

Session 3

 

Juvenile Myelomonocytic Leukemia II

14.30 - 15.00

IS 04

M. Loh
Novel therapies in JMML/MDS

15.00 - 15.15

CO 09

T.Witte
Genome-wide DNA methylation profiling in JMML (54)

15.15 - 15.30

CO 10

H. Sakaguchi
Aberrant DNA methylation in JMML (36)

15.30 - 15.45

CO 11

A. Poetsch
Ras GTPase-activating protein 4 is silenced in JMML through loss of chromosome 7 and DNA hypermethylation (52)

15.45 - 16.00

CO 12

A.M. Cseh
Therapy with azacitidine in pediatric MDS and JMML: a retrospective (99)

 

 

 

16.00-16.30

 

Coffee break

     

Session 4

 

Acquired Bone Marrow Failure

16.30 - 17.00

IS 05

M. Ito
How to approach the bone marrow failures in childhood by bone marrow pathology

17.00 - 17.15

CO 13

A.Hama
Histological classification of acquired bone marrow failure in children (23)

17.15 - 17.30

CO 14

M. Novakova
Composition of T cells in bone marrow failure and in control samples reveals differences between pediatr

17.30 - 17.45

CO 15

S.Hirabayashi
Recurrent 6pLOH is the most common somatic copy
number neutral lesion in RCC and occures infrequently in SAA (110)

17.45 - 18.00

CO 16

H. Sakaguchi
Lymphocyte telomere length in children with acquired
BM failure (37)

 

 

 

18.00 - 19.30

 

Welcome reception

     
   
 
Symposium Secretariat: CZECH-IN s.r.o., 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | [email protected]
Copyright © 2011 ewogmds2012.com | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2